Recently, the “Form & Seminar on TCM Inheritance and Development” hosted by AIPPMCM was successfully held in Macau. The experts in TCM from various regions gathered to together discuss the experience in TCM development and witness the achievements in TCM innovation.
For the past few years, with a growing concern about premature aging of various physiological functions, anti-aging research has become a frontier issue and hot topic in the life science field around the world. Modern science and technologies bring new vigor and vitality into anti-aging with TCM. At the Forum, Prof. Xu Fengqin from Xiyuan Hospital of China Academy of Chinese Medical Science delivered a special report on the latest achievements in scientific research on anti-aging with TCM, and the up-to-date academic research in aging based on the Qi Collateral Theory and the Essence-qi-spirit Theory around premature senescence and aging.
She indicated that, according to the latest research, Bazi Bushen Capsules, an innovative TCM, could delay global senescence by interfering with DNA methylation, and thus was an example for the inheritance and innovative development of TCM. With elaborate scientific evidence, the report further revealed that the Bazi Bushen Capsules showed definite improvement effects in the hypofunction and age-related diseases of the digestive, circulatory, nervous, immune, respiratory, integumentary, skeletal, muscular and genital systems.
▲She shared the latest scientific research achievements in anti-aging with TCM online
The TCM at the Guangdong-Hong Kong-Macao Greater Bay Area accelerated its integrated development after standing the test of the COVID-19 pandemic. How to continuously assure respiratory health remains a topic requiring long-term attention from all sectors of society in the face of coexisting more changeable hot humid climate and infectious respiratory diseases such as cold and flu under the current regular epidemic prevention and control.
▲Prof. Feng Cuiling gave a keynote speech titled Research on TCM in the Prophylaxis and Treatment of Respiratory Disorders.
Prof. Feng Cuiling from Peking University People’s Hospital made a keynote speech titled Research on TCM in the Prophylaxis and Treatment of Respiratory Disorders. She reported the clinical and experimental studies of TCM in the prophylaxis and treatment of viral infectious disorders of the respiratory tract in detail from the perspective of such major threats as COVID-19 and flu in the post-pandemic era. She highlighted that Lianhua Qingwen, one of the “three drugs and three prescriptions” for the prophylaxis of COVID-19 screened by the state, could produce the antimicrobial and anti-inflammatory, broad-spectrum antiviral and body immunity-enhanced pharmacological actions by “systemic regulation and multiple-target treatment”. A number of experimental studies demonstrated that it had favorable inhibitory effects on influenza A virus (H1N1, H3N2, etc.), influenza B virus, SARS-CoV-2 and so on, and could shorten the duration of discomfort symptom and accelerated the recovery. It is learned that Lianhua Qingwen has been granted the registration approval in nearly 30 countries globally, as well as Hong Kong and Macau.
Shi Chongrong, president of AIPPMCM, remarked in an interview that the TCM in Macau would embrace a tremendous development opportunity with multiple Macau-benefiting policies introduced in the Guangdong-Hong Kong-Macao Greater Bay Area, and should rely on regional advantages, make good use of the fusion between TCM and modern information technologies and continuously and vigorously promote the modernization and international development of the TCM industry to contribute to the human health.